[HTML][HTML] Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis

O Menyhárt, B Győrffy - Computational and structural biotechnology journal, 2021 - Elsevier
While cost-effective high-throughput technologies provide an increasing amount of data, the
analyses of single layers of data seldom provide causal relations. Multi-omics data …

Current status of immune checkpoint inhibitors for gastric cancer

K Kono, S Nakajima, K Mimura - Gastric cancer, 2020 - Springer
Recent breakthrough results from immune checkpoint inhibitors (ICI) have paved the way to
a new era of cancer immunotherapy. In particular, inhibition of programmed death-1 (PD …

[HTML][HTML] High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features

X Liu, MG Choi, K Kim, KM Kim, ST Kim, SH Park… - … -Research and Practice, 2020 - Elsevier
Background The programmed death receptor ligand 1 (PD-L1) immunohistochemistry (IHC)
22C3 pharmDx assay is a widely used selection method for pembrolizumab treatment in …

muTarget: a platform linking gene expression changes and mutation status in solid tumors

Á Nagy, B Győrffy - International journal of cancer, 2021 - Wiley Online Library
Large oncology repositories have paired genomic and transcriptomic data for all patients.
We used these data to perform two independent analyses: to identify gene expression …

The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment

N Bolandi, A Derakhshani, N Hemmat… - International Journal of …, 2021 - mdpi.com
Gastric cancer (GC), with a heterogeneous nature, is the third leading cause of death
worldwide. Over the past few decades, stable reductions in the incidence of GC have been …

Construction and analysis of the tumor-specific mRNA–miRNA–lncRNA network in gastric cancer

X Zheng, X Wang, L Zheng, H Zhao, W Li… - Frontiers in …, 2020 - frontiersin.org
Weighted correlation network analysis (WGCNA) is a statistical method that has been widely
used in recent years to explore gene co-expression modules. Competing endogenous RNA …

[HTML][HTML] Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards

R Danesi, S Fogli, S Indraccolo, M Del Re, AP Dei Tos… - ESMO open, 2021 - Elsevier
Highlights•The identification of oncogenic drivers offers the opportunity to develop target-
specific drugs.•The inhibition of crucial pathways realizes the principle of druggable target to …

Comprehensive outline of whole exome sequencing data analysis tools available in clinical oncology

Á Bartha, B Győrffy - Cancers, 2019 - mdpi.com
Whole exome sequencing (WES) enables the analysis of all protein coding sequences in
the human genome. This technology enables the investigation of cancer-related genetic …

SLC11A1 associated with tumor microenvironment is a potential biomarker of prognosis and immunotherapy efficacy for colorectal cancer

Y Ma, L Zhan, J Yang, J Zhang - Frontiers in pharmacology, 2022 - frontiersin.org
Colorectal cancer (CRC) is one of the most lethal cancers of the digestive system. The tumor
microenvironment (TME) plays a central role in the initiation and development of CRC …

Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis

X Lei, M Zhang, B Guan, Q Chen, Z Dong, C Wang - Human Genomics, 2021 - Springer
Background Liver cancer is one of the most common cancers and causes of cancer death
worldwide. The objective was to elucidate novel hub genes which were benefit for …